Abstract
Background. A point-of-care glucose testing (POCT) is an essential component of care in patients with hyperglycemia and hypoglycemia in inpatient and outpatient medical facilities (MFs). In MFs conventional glucose meters designed for self-monitoring by patients with diabetes are commonly used for POCT. These home-use meters have two serious disadvantages: the first is large measurement bias and the second – they can’t be integrated into laboratory information systems, so measurement data have to be recorded into patient charts manually. Both factors may lead to medical errors. It is reasonable to use in the MFs specialized POCT glucose meters, as they are superior to conventional ones in accuracy and may be easily connected to laboratory information systems. With this in mind, physicians at the Russian Children’s Clinical Hospital – Branch of Pirogov Russian National Research Medical University – decided to substitute conventional meters with the Accu-Chek Inform II POCT meter, however, after preliminary performance assessment of the model.
Aim. To test the Accu-Chek Inform II performance characteristics: accuracy, linearity, repeatability, mean absolute relative difference.
Materials and methods. Performance of the Accu-Chek Inform II was tested by comparing the results of parallel CGL measurements with the meter and reference laboratory analyzer in capillary blood samples. Overall, 99 parallel CGL measurements were made in 45 samples. Accuracy was evaluated according to the ISO 15197-2013 and POCT12-A3 criteria.
Results. The Accu-Chek Inform II meter met the requirements of ISO 15197-2013 and POCT12-A3 and demonstrated high linearity (correlation coefficient, r=1.0), good repeatability (mean coefficient of variation, CV=1.38%) and acceptable mean absolute relative difference (4.9%).
Conclusion. The Accu-Chek Inform II POCT glucose meter may be efficiently and safely used in inpatient and outpatient MFs and particularly in pediatric clinics.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice,General Medicine
Reference18 articles.
1. Impact of hyperglycemia on the results of percutaneous coronary interventions in patients with acute ST-segment elevation myocardial infarction
2. Hyperglycemia in hospitalized patients of a tertiary care hospital: prevalence and treatment in two cross-sectional evaluations (2011-2020)
3. A Systematic Approach for the Prevention and Reduction of Hypoglycemia in Hospitalized Patients
4. International Organization for Standardization. ISO 15197:2013 In vitro diagnostic test systems requirements for blood-GLucose monitoring systems for self-testing in managing diabetes mellitus. Available at: https://www.iso.org/standard/54976.html#:~:text=ISO%2015197 %3A2013%20 specifies %20requirements,performance%20by%20the%20intended%20users/ Accessed: 29.11.2023.
5. ГОСТ Р ИСО 15197-2015. Национальный стандарт Российской Федерации «Тест-системы для диагностики in vitro. Требования к системам мониторинга глюкозы в крови для самоконтроля при лечении сахарного диабета». Федеральное агентство по техническому регулированию и метрологии. М.: Стандартинформ, 2015. Режим доступа: https://docs.cntd.ru/document/1200120137. Ссылка активна на 29.11.2023 [GOST R ISO 15197-2015. Natsional'nyi standart Rossiiskoi Federatsii “Test-sistemy dlia diagnostiki in vitro. Trebovaniia k sistemam monitoringa gliukozy v krovi dlia samokontrolia pri lechenii sakharnogo diabeta”. Federal'noe agentstvo po tekhnicheskomu regulirovaniiu i metrologii. Moscow: Standartinform, 2015. Available at: https://docs.cntd.ru/document/1200120137. Accessed: 29.11.2023 (in Russian)].